A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

Fibronectin (FN) represents the mixture of a number of structurally different molecules (isoforms) whose make-up varies depending on the FN sources. FN from cultured transformed human cells has a very different isoform composition with respect to its normal counterpart. In fact, SV- 40-transformed WI-38VAI3 human fibroblasts produce high levels of a FN isoform (B-FN) which is very poorly expressed in their normal, WI-38, counterpart. We have recently demonstrated that the B-FN isoform derives from a differential splicing pattern of the FN primary transcript which leads, in transformed cells, to a high level expression of the exon ED-B (Zardi, L., B. Carnemolla, A. Siri, T. E. Petersen, G. Paolella, G. Sebastio, and F. E. Baralle. 1987. EMBO (Eur. Mol. Biol. Organ.) J. 6:2337-2342). Here we report on the production and characterization of a monoclonal antibody (BC-1) which recognizes an epitope within the protein sequence coded for by the ED-B exon. This monoclonal antibody makes it possible to carry out immunohistochemical analysis of the distribution of the ED-B-containing FN isoform (B-FN) in human tissues. The results show that while in normal, adult, human tissues total FN has a widespread distribution, the B-FN isoform is restricted only to synovial cells, to some vessels and areas of the interstitium of the ovary, and to the myometrium. On the contrary, the B-FN isoform has a much greater expression in fetal and tumor tissues. These results demonstrate that, in vivo, different FN isoforms have a differential distribution and indicate that the B-FN isoform may play a role in ontogenesis and oncogenetic processes.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  R. Hynes,et al.  Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells , 1987, Molecular and cellular biology.

[3]  A. Kornblihtt,et al.  Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Hynes,et al.  Multiple sites of alternative splicing of the rat fibronectin gene transcript. , 1987, The EMBO journal.

[5]  F. Baralle,et al.  Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. , 1987, The EMBO journal.

[6]  B. Nadal-Ginard,et al.  Developmentally induced, muscle-specific trans factors control the differential splicing of alternative and constitutive troponin T exons , 1987, Cell.

[7]  R. Owens,et al.  Localization of the cellular‐fibronectin‐specific epitope recognized by the monoclonal antibody IST‐9 using fusion proteins expressed in E. coli , 1987, FEBS letters.

[8]  J. Taylor‐Papadimitriou,et al.  Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells , 1987, The Journal of cell biology.

[9]  A. Kornblihtt,et al.  A family of fibronectin mRNAs in human normal and transformed cells. , 1986, Biochimica et biophysica acta.

[10]  M. Humphries,et al.  Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion , 1986, The Journal of cell biology.

[11]  L. Zardi,et al.  Transformed human cells release different fibronectin variants than do normal cells , 1986, The Journal of cell biology.

[12]  R. Hynes,et al.  Cell-type-specific fibronectin subunits generated by alternative splicing. , 1986, The Journal of biological chemistry.

[13]  L. Zardi,et al.  Large-scale procedure for the purification of fibronectin domains. , 1986, Analytical biochemistry.

[14]  S. Hakomori,et al.  The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Kornblihtt,et al.  Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. , 1985, The EMBO journal.

[16]  R. Hynes,et al.  On the origin of species of fibronectin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Zardi,et al.  Elution of fibronectin proteolytic fragments from a hydroxyapatite chromatography column. A simple procedure for the purification of fibronectin domains. , 1985, European journal of biochemistry.

[18]  A. Kornblihtt,et al.  Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. , 1984, Nucleic acids research.

[19]  J. McGee,et al.  Fibronectin in disease , 1984, The Journal of pathology.

[20]  A. Kornblihtt,et al.  Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. , 1984, The EMBO journal.

[21]  G. Freeman,et al.  Sequential expression of new gene programs in inducer T-cell clones. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Hynes,et al.  Plasma fibronectin is synthesized and secreted by hepatocytes. , 1983, The Journal of biological chemistry.

[23]  K. Sekiguchi,et al.  Topological arrangement of four functionally distinct domains in hamster plasma fibronectin: a study with combination of S-cyanylation and limited proteolysis. , 1983, Biochemistry.

[24]  J. Vieira,et al.  The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. , 1982, Gene.

[25]  E. Ruoslahti,et al.  Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule , 1981, Cell.

[26]  G. Viale,et al.  A simplified procedure for the preparation of antibodies to serum fibronectin. , 1980, Journal of immunological methods.

[27]  L. Zardi,et al.  Somatic cell hybrids producing antibodies specific to human fibronectin , 1980, International journal of cancer.

[28]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[29]  W. D. Gardner,et al.  Fibronectin: a chromatin-associated protein? , 1979, Cell.

[30]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Vaheri,et al.  Distribution of a major connective tissue protein, fibronectin, in normal human tissues , 1978, The Journal of experimental medicine.

[32]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[33]  B. Nadal-Ginard,et al.  Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes. , 1987, Annual review of biochemistry.

[34]  P. Sharp,et al.  Splicing of messenger RNA precursors. , 1987, Science.

[35]  S. Leff,et al.  Complex transcriptional units: diversity in gene expression by alternative RNA processing. , 1986, Annual review of biochemistry.

[36]  A. Kornblihtt,et al.  Fibronectin, the generation of multiple polypeptides from a single gene. , 1986, Oxford surveys on eukaryotic genes.

[37]  L. G. Davis,et al.  Basic methods in molecular biology , 1986 .

[38]  R. Hynes,et al.  Molecular biology of fibronectin. , 1985, Annual review of cell biology.

[39]  P. Sharp,et al.  Splicing of messenger RNA precursors. , 1985, Harvey lectures.

[40]  K M Yamada,et al.  Cell surface interactions with extracellular materials. , 1983, Annual review of biochemistry.

[41]  Akiyama Sk,et al.  Fibronectin in disease. , 1983, Monographs in pathology.

[42]  K. Alitalo,et al.  Pericellular matrix in malignant transformation. , 1982, Advances in cancer research.

[43]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[44]  Kiyotoshi Sekiguchig,et al.  Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts : Studies with domain-specific antibodies , 2022 .